Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/314577
Title: | Comparison of Efficacy And Their Combination With Epalrestat in Diabetic Neuropathy Double Blind Clinical Study |
Researcher: | Ravinder Singh |
Guide(s): | Thakur Gurjeet Singh and Harbir Kaur Rao |
Keywords: | Clinical Pre Clinical and Health Pharmacology and Pharmacy Pharmacology and Toxicology |
University: | Chitkara University, Punjab |
Completed Date: | 2019 |
Abstract: | Type 2 diabetes mellitus (T2DM) is a metabolic syndrome characterized by newlinehyperglycemia and chronic hyperglycemia is primary cause of neuropathy and newlineneuropathic pain. Diabetic neuropathy (DN) is one of the most frequent newlinecomplications of diabetes mellitus. In spite of so many therapeutic options, newlinemortality rate is very high so our study was aimed to compare the efficacy and newlinesafety of Pregabalin, Duloxitene and their combination with Epalristat in T2DM newlineneuropathic patients. newline |
Pagination: | |
URI: | http://hdl.handle.net/10603/314577 |
Appears in Departments: | Faculty of Pharmacy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
13 - case record form appendices 2 iv-viii.pdf | Attached File | 218.65 kB | Adobe PDF | View/Open |
1. introduction.pdf | 154.99 kB | Adobe PDF | View/Open | |
2. review new.pdf | 1.41 MB | Adobe PDF | View/Open | |
3. aim and objective.pdf | 227.42 kB | Adobe PDF | View/Open | |
4. material and methods 30 may.pdf | 358.26 kB | Adobe PDF | View/Open | |
6. discussion.pdf | 128.95 kB | Adobe PDF | View/Open | |
7. conclusion.pdf | 144.22 kB | Adobe PDF | View/Open | |
80_recommendation.pdf | 1.57 MB | Adobe PDF | View/Open | |
8. bibliography final.pdf | 223.78 kB | Adobe PDF | View/Open | |
certificate page.pdf | 5.17 MB | Adobe PDF | View/Open | |
list of figure.pdf | 11.24 MB | Adobe PDF | View/Open | |
title page.pdf | 230.79 kB | Adobe PDF | View/Open | |
vpt.pdf | 292.46 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Altmetric Badge: